Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Treatment Outcomes of Isoniazid-Resistant (Rifampicin Susceptible) Tuberculosis Patients in Uzbekistan, 2017–2018

Autor: Dilyara Nabirova, Ajay M. V. Kumar, Zayniddin Sayfutdinov, Jamshid Gadoev, Laziz Turaev, Nargiza Parpieva, Sevak Alaverdyan, Sanjar Sultanov

Publikováno v: International Journal of Environmental Research and Public Health, Vol 18, Iss 2965, p 2965 (2021)
International Journal of Environmental Research and Public Health
Volume 18
Issue 6

Tuberculosis patients “resistant to isoniazid and susceptible to rifampicin (Hr-TB)” remain neglected, despite a high burden and poor outcomes. The World Health Organization (WHO) recommends a 6 month regimen consisting of levofloxacin, rifampici

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1448c84760143f48e938bc827528716f
https://doi.org/10.3390/ijerph18062965

IFNG-mediated immune responses enhance autophagy against Mycobacterium tuberculosis antigens in patients with active tuberculosis.

Autor: Rovetta AI; a Departamento de Química Biológica; Facultad de Ciencias Exactas y Naturales; Universidad de Buenos Aires (UBA) ; Buenos Aires , Argentina., Peña D, Hernández Del Pino RE, Recalde GM, Pellegrini J, Bigi F, Musella RM, Palmero DJ, Gutierrez M, Colombo MI, García VE

Publikováno v: Autophagy [Autophagy] 2014; Vol. 10 (12), pp. 2109-21.